Market Place
Sourcing Support
Vivera Prevails in Litigation Against Former Commissioner Pedram Salimpour
26 Oct 2023 //
ACCESSWIRE
Vivera Welcomes Former FDA Investigator Dennis Moore as Regulatory Advisor
14 Feb 2023 //
PR NEWSWIRE
Vivera Expands TABMELT Global Licensing Reach with Grant of Israel Patent
05 Jan 2023 //
PR NEWSWIRE
Vivera Welcomes Publicist Amanda Whitcroft as Director of Public Relations
07 Dec 2022 //
PRNEWSWIRE
Vivera’s Tabmelt platform receives Israel patent
29 Oct 2022 //
PHARMABIZ
Vivera Enters $6B Market with Feedback Device Patent Allowance
25 Oct 2022 //
PRNEWSWIRE
Vivera Welcomes Healthcare Founder and CEO Lea Ramirez to its Advisory Board
20 Oct 2022 //
PRNEWSWIRE
Vivera Appoints Regulatory Leader Dr. Geetha Rao to Advisory Board
12 Oct 2022 //
PRNEWSWIRE
Sublingual delivery firm hits back against SEC fraud complaint
04 Oct 2022 //
FIERCEPHARMA
Vivera Files Response Defending Against The SEC`s Recent Threat Of A Civil Suit
30 Sep 2022 //
PRNEWSWIRE
Vivera Receives 3rd Patent for ZICOH, Expanding Into $500B Prescription Market
28 Sep 2022 //
PRNEWSWIRE
Vivera Offers Solution Beyond Teva`s Recent $4.35B Opioid Settlement
04 Aug 2022 //
PRNEWSWIRE
Vivera Appoints Dr. Guido Jouret as Interim Chief Technology Officer
30 Jun 2022 //
PRNEWSWIRE
Vivera Welcomes Two Veteran Advisors to Its Technology Board
23 Jun 2022 //
PRNEWSWIRE
Vivera Appoints Dr. Fabio Macciardi as Neurogenetics Scientific Advisor
16 Jun 2022 //
PRNEWSWIRE
Vivera Receives 3rd U.S. Patent Allowance for ZICOH Drug Delivery Device
25 May 2022 //
PRNEWSWIRE
Vivera Partners with NINDS of NIH to Identify Potential Stuttering Treatments
17 May 2022 //
PRNEWSWIRE
Vivera Enters $23 Billion Telehealth Industry with Patent Allowance for MDZone
21 Apr 2022 //
PRNEWSWIRE
Vivera Pharma Issues Statement Regarding LuSys Laboratories COVID-19 Tests
14 Jan 2022 //
PRNEWSWIRE
Vivera Named COVID-19 Testing Partner for the 2021 Indigenous Bowl
02 Dec 2021 //
PRNEWSWIRE
Vivera Announces Launch of New Testing Software, LabPort
23 Nov 2021 //
PRNEWSWIRE
Vivera Pharmaceuticals Names Dr. Aaron Kheriaty as its Medical Ethics Advisor
17 Nov 2021 //
PRNEWSWIRE
Vivera Pharmaceuticals Offers No-Cost COVID-19 Testing to LAPD and LAFD
11 Nov 2021 //
PRNEWSWIRE
Vivera Pharmaceuticals Announces New BioSciences Division Focused
26 Oct 2021 //
PRNEWSWIRE
Vivera Pharmaceuticals Collaborates With DoctorsOne Healthcare Systems
21 Sep 2021 //
PRNEWSWIRE
Vivera Joins Forces with Doc1 Health & Manny Pacquiao for Vaccine Campaign
14 Sep 2021 //
PRNEWSWIRE
$500M Defamation Lawsuit Against USA Today and Its Executives Continues
09 Sep 2021 //
PRNEWSWIRE
Vivera Pharma’s Zicoh receives US patent
23 Aug 2021 //
PHARMABIZ
Vivera Pharmaceuticals Supports Naomi Osaka`s Stance
08 Jul 2021 //
PR NEWSWIRE
Parexel International, on $8.5 Billion Acquisition by Goldman Sachs
07 Jul 2021 //
PR NEWSWIRE
Parexel International, on $8.5 Billion Acquisition by Goldman Sachs
07 Jul 2021 //
PR NEWSWIRE
Vivera Pharmaceuticals Partners with Areum Bio LLC and Access Bio
30 Jun 2021 //
PR NEWSWIRE
Vivera Pharmaceuticals Welcomes Gonçalo Leal as Scientific Advisor
26 Jun 2021 //
PR NEWSWIRE
Vivera Pharmaceuticals Welcomes Shawn Ray to Ambassador Board
17 Jun 2021 //
PRNEWSWIRE
Vivera Pharmaceuticals Welcomes Shawn Ray to Ambassador Board
17 Jun 2021 //
PRNEWSWIRE
Vivera Names Dr. Bobby W. Sandage, Jr. to Company`s Board of Advisors
15 Jun 2021 //
PRNEWSWIRE
Vivera Announces $440 Million in Backing by JR Dallas Management
25 Nov 2020 //
PRNEWSWIRE
Vivera Pharmaceuticals Selected to Screen Travellers to the UAE for COVID-19
07 Oct 2020 //
PRNEWSWIRE
Vivera Pharmaceuticals announces one-step COVID-19 testing cartridge
13 Aug 2020 //
PRNEWSWIRE
Vivera Pharmaceuticals files multi-million dollar lawsuit against USA Today
30 Jun 2020 //
PRNEWSWIRE
Vivera Pharmaceuticals Issues Response to Recent Article
16 Jun 2020 //
PRNEWSWIRE
Vivera Pharmaceuticals Files First of Two US Made COVID-19 Antibody Tests
10 Jun 2020 //
PRNEWSWIRE
Vivera files patents for future at-home antibodies testing; approval
09 Jun 2020 //
PRNEWSWIRE
